Literature DB >> 872450

Purification of normal human eosinophils using the different binding capacities of blood leucocytes for complexed rabbit IgG.

P C Tai, C J Spry.   

Abstract

A method has been developed for separating eosinophils from other types of leucocyte in normal individuals. Erythrocytes are sedimented with dextran, and mononuclear cells are removed on an isotonic density gradient of ficoll and sodium diatrizoate. The eosinophils and neutrophils are then washed and sedimented onto plastic petri dishes coated with human IgG and rabbit anti-human IgG antibody; As neutrophils and monocytes have Fc-binding sites for complexed rabbit IgG they attach to the dishes, and the unabsorbed normal eosinophils which lack this binding site are eluted in a purified suspension. The mean purity of the eosinophils obtained in this way was 70%, range 50-90%, and the mean yield was 49%, range 21-81%. This method provides purified eosinophils from normal people without subjecting them to osmotic or plasma membrane stimulation. Normal eosinophils which are prepared in this way are particularly suitable for studying the ways in which eosinophils became altered in disease states.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 872450      PMCID: PMC1540766     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  16 in total

1.  A method for obtaining concentrates of eosinophils from blood.

Authors:  R F Alexander; A I Spriggs
Journal:  J Clin Pathol       Date:  1962-03       Impact factor: 3.411

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  A simple and efficient method of separating peripheral-blood leucocytes for in-vitro studies.

Authors:  L Hulliger; A A Blazkovec
Journal:  Lancet       Date:  1967-06-17       Impact factor: 79.321

4.  In vitro studies of immunologically induced secretion of mediators from cells and related phenomena.

Authors:  E L Becker; P M Henson
Journal:  Adv Immunol       Date:  1973       Impact factor: 3.543

5.  Production of monospecific rabbit antihuman eosinophil serums and demonstration of a blocking phenomenon.

Authors:  A A Mahmoud; R W Kellermeyer; K S Warren
Journal:  N Engl J Med       Date:  1974-02-21       Impact factor: 91.245

6.  Selective stimulation and purification of eosinophils and neutrophils from guinea pig peritoneal fluids.

Authors:  G J Gleich; D Loegering
Journal:  J Lab Clin Med       Date:  1973-09

7.  Changes in the carbohydrate metabolism of mitogenically stimulated human peripheral lymphocytes. I. Stimulation by phytohaemagglutinin.

Authors:  D Roos; J A Loos
Journal:  Biochim Biophys Acta       Date:  1970-12-29

8.  Isolation of human eosinophils and their lymphocyte-like rosetting properties.

Authors:  R Sher; A Glover
Journal:  Immunology       Date:  1976-09       Impact factor: 7.397

9.  ISOLATION OF GRANULES FROM EOSINOPHIL LEUCOCYTES AND STUDY OF THEIR ENZYME CONTENT.

Authors:  G T ARCHER; J G HIRSCH
Journal:  J Exp Med       Date:  1963-08-01       Impact factor: 14.307

10.  FORMATION OF CHARCOT-LEYDEN CRYSTALS IN HUMAN EOSINOPHILS AND BASOPHILS AND STUDY OF THE COMPOSITION OF ISOLATED CRYSTALS.

Authors:  G T ARCHER; A BLACKWOOD
Journal:  J Exp Med       Date:  1965-07-01       Impact factor: 14.307

View more
  4 in total

Review 1.  Eosinophils. Assays and interpretation.

Authors:  D E Maddox
Journal:  Clin Rev Allergy       Date:  1988

2.  T lymphocyte colony-forming capacity of patients with immunodeficiency diseases: relationship of colony formation to E rosette formation and lymphocyte proliferation.

Authors:  H G Herrod; W R Valenski
Journal:  Clin Exp Immunol       Date:  1981-09       Impact factor: 4.330

3.  An improved method for the isolation of eosinophilic leukocytes from normal human blood.

Authors:  P Portmann; P Köppel; A Jörg
Journal:  Experientia       Date:  1980-01-15

4.  Human eosinophils and parasitic diseases. II. Characterization of two cell fractions isolated at different densities.

Authors:  C De Simone; G Donneli; D Meli; F Rosati; F Sorice
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.